News | February 13, 2009

American Shared Hospital Services to Develop Proton Beam Radiation Therapy Facility in Bay Area

February 13, 2009 - American Shared Hospital Services (AMS) said that it is developing a proton beam radiation therapy (PBRT) facility in the San Francisco Bay Area.

AMS has entered into a non-binding agreement with Varian Medical Systems under which Varian will supply proton therapy equipment for the planned three-room treatment facility. AMS currently is evaluating several potential sites, and is forming a consortium of hospital partners for what should be the first PBRT center in Northern California.

"Widely regarded as the optimal radiation treatment for a wide variety of cancers, proton beam radiation therapy is the most significant advance in radiation oncology in a generation. AMS is proud to take the lead in making this advanced therapy available to cancer patients in the Bay Area," said Ernest A. Bates, M.D., chairman and CEO of American Shared Hospital Services. "Subject to financing and FDA clearance, we and our partners hope to begin treating patients at our PBRT facility in San Francisco by 2011."

AMS has previously announced contracts to place PBRT devices at Tufts Medical Center in Boston, Orlando Regional Healthcare (with professional services to be provided exclusively by M.D. Anderson Cancer Center Orlando) and Long Beach Memorial Medical Center (in partnership with A.M. Nisar Syed & Associates, a leading radiation oncology group).

"We are negotiating contracts to place additional PBRT systems in medical centers throughout the country," Dr. Bates said.

For more information: www.ashs.com, www.varian.com

Related Content

Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Feature | Proton Therapy | March 06, 2018 | By Jeff Zagoudis
Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
IBA Announces First Patient Treated with Proteus PLUS in The Netherlands
News | Proton Therapy | January 25, 2018
January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG)
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
Overlay Init